SE8904186D0 - Adenosine derivatives, their production and use - Google Patents
Adenosine derivatives, their production and useInfo
- Publication number
- SE8904186D0 SE8904186D0 SE8904186A SE8904186A SE8904186D0 SE 8904186 D0 SE8904186 D0 SE 8904186D0 SE 8904186 A SE8904186 A SE 8904186A SE 8904186 A SE8904186 A SE 8904186A SE 8904186 D0 SE8904186 D0 SE 8904186D0
- Authority
- SE
- Sweden
- Prior art keywords
- alkyl
- production
- adenosine derivatives
- derivatives
- adenosines
- Prior art date
Links
- 150000003835 adenosine derivatives Chemical class 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract 1
- 150000003838 adenosines Chemical class 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 210000003989 endothelium vascular Anatomy 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 125000005394 methallyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3841881 | 1988-12-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8904186D0 true SE8904186D0 (sv) | 1989-12-12 |
| SE8904186L SE8904186L (sv) | 1991-06-13 |
Family
ID=6369027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8904186A SE8904186L (sv) | 1988-12-13 | 1989-12-12 | Adenosinderivat, deras framstaellning och anvaendning |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5534503A (sv) |
| JP (2) | JPH0725786B2 (sv) |
| KR (1) | KR900009647A (sv) |
| AT (1) | AT397964B (sv) |
| AU (1) | AU618865B2 (sv) |
| BE (1) | BE1003632A3 (sv) |
| CA (1) | CA2005110A1 (sv) |
| CH (1) | CH678327A5 (sv) |
| CS (1) | CS411191A3 (sv) |
| CY (1) | CY1829A (sv) |
| DE (1) | DE3940021C2 (sv) |
| DK (1) | DK626989A (sv) |
| ES (1) | ES2022771A6 (sv) |
| FR (1) | FR2640271B1 (sv) |
| GB (1) | GB2226027B (sv) |
| HK (1) | HK70895A (sv) |
| HU (1) | HU211248A9 (sv) |
| IE (1) | IE65506B1 (sv) |
| IL (1) | IL92634A (sv) |
| IT (1) | IT1237431B (sv) |
| LU (1) | LU87639A1 (sv) |
| MX (1) | MX9203613A (sv) |
| MY (1) | MY106333A (sv) |
| NL (1) | NL8903054A (sv) |
| NZ (1) | NZ231701A (sv) |
| PH (1) | PH27533A (sv) |
| SE (1) | SE8904186L (sv) |
| SG (1) | SG8695G (sv) |
| ZA (1) | ZA899528B (sv) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0725785B2 (ja) * | 1989-01-11 | 1995-03-22 | 日本臓器製薬株式会社 | アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物 |
| DE4037363A1 (de) * | 1990-04-09 | 1991-10-10 | Europ Lab Molekularbiolog | 2-0-alkylnukleotide sowie polymere, die solche nukleotide enthalten |
| ATE147074T1 (de) * | 1990-09-25 | 1997-01-15 | Rhone Poulenc Rorer Int | Verbindungen welche antihypertensive und antiischemische eigenschaften besitzen |
| US5561134A (en) * | 1990-09-25 | 1996-10-01 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| HUT61567A (en) * | 1990-12-07 | 1993-01-28 | Sandoz Ag | Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate |
| GB9111580D0 (en) * | 1991-05-30 | 1991-07-24 | Wellcome Found | Nucleoside derivative |
| EP0601322A3 (en) * | 1992-10-27 | 1994-10-12 | Nippon Zoki Pharmaceutical Co | Adenosine deaminase inhibitor. |
| BR9507683A (pt) * | 1994-05-10 | 1997-09-23 | Sandoz Ag | Derivados de adenosina |
| US6107300A (en) * | 1996-03-27 | 2000-08-22 | Dupont Pharmaceuticals | Arylamino fused pyrimidines |
| JP3619017B2 (ja) | 1998-06-24 | 2005-02-09 | 日本臓器製薬株式会社 | 新規アラビノシルアデニン誘導体 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL130136C (sv) * | 1966-10-20 | |||
| DE2628202A1 (de) * | 1976-06-23 | 1977-12-29 | Max Planck Gesellschaft | Verfahren zur herstellung von 2'-substituierten-d-ribofuranosylpurinderivaten |
| CA1239397A (en) * | 1983-08-01 | 1988-07-19 | James A. Bristol | N.sup.6-substituted adenosines |
| DE3406533A1 (de) * | 1984-02-23 | 1985-08-29 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten |
| AU575438B2 (en) * | 1984-10-26 | 1988-07-28 | Warner-Lambert Company | N6 - substituted deoxyribose analogues of adenosines |
| US4755594A (en) * | 1986-01-31 | 1988-07-05 | Warner-Lambert Company | N6 -substituted adenosines |
| US4780452A (en) * | 1986-09-08 | 1988-10-25 | Burroughs Wellcome Co. | F-substituted-3-β-D-ribofuranosyl-3H-imidazo[4,5-b]pyridines and pharmaceutical compositions thereof |
| AU8274187A (en) * | 1986-10-31 | 1988-05-25 | Warner-Lambert Company | Heteroaromatic derivatives of adenosine |
| JPH0723394B2 (ja) * | 1986-11-27 | 1995-03-15 | 日本臓器製薬株式会社 | 新規アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物 |
| US4962194A (en) * | 1987-04-02 | 1990-10-09 | Warner-Lambert Company | Method of preparing 51,N6-disubstituted adenosines from inosines |
| GB8729994D0 (en) * | 1987-12-23 | 1988-02-03 | Glaxo Group Ltd | Chemical compounds |
| JPH0725785B2 (ja) * | 1989-01-11 | 1995-03-22 | 日本臓器製薬株式会社 | アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物 |
-
1989
- 1989-11-10 GB GB8925439A patent/GB2226027B/en not_active Expired - Lifetime
- 1989-12-04 BE BE8901293A patent/BE1003632A3/fr not_active IP Right Cessation
- 1989-12-04 FR FR8916087A patent/FR2640271B1/fr not_active Expired - Fee Related
- 1989-12-04 DE DE3940021A patent/DE3940021C2/de not_active Expired - Fee Related
- 1989-12-08 LU LU87639A patent/LU87639A1/fr unknown
- 1989-12-11 CA CA002005110A patent/CA2005110A1/en not_active Abandoned
- 1989-12-11 AU AU46172/89A patent/AU618865B2/en not_active Ceased
- 1989-12-11 CH CH4442/89A patent/CH678327A5/de not_active IP Right Cessation
- 1989-12-11 MY MYPI89001738A patent/MY106333A/en unknown
- 1989-12-11 NZ NZ231701A patent/NZ231701A/xx unknown
- 1989-12-11 IL IL9263489A patent/IL92634A/en not_active IP Right Cessation
- 1989-12-12 AT AT0280489A patent/AT397964B/de not_active IP Right Cessation
- 1989-12-12 KR KR1019890018330A patent/KR900009647A/ko not_active Application Discontinuation
- 1989-12-12 JP JP1324880A patent/JPH0725786B2/ja not_active Expired - Lifetime
- 1989-12-12 IT IT04864089A patent/IT1237431B/it active IP Right Grant
- 1989-12-12 IE IE396589A patent/IE65506B1/en not_active IP Right Cessation
- 1989-12-12 PH PH39675A patent/PH27533A/en unknown
- 1989-12-12 SE SE8904186A patent/SE8904186L/sv not_active Application Discontinuation
- 1989-12-12 DK DK626989A patent/DK626989A/da not_active Application Discontinuation
- 1989-12-13 ES ES8904209A patent/ES2022771A6/es not_active Expired - Lifetime
- 1989-12-13 ZA ZA899528A patent/ZA899528B/xx unknown
- 1989-12-13 NL NL8903054A patent/NL8903054A/nl not_active Application Discontinuation
-
1991
- 1991-12-27 CS CS914111A patent/CS411191A3/cs unknown
-
1992
- 1992-06-26 MX MX9203613A patent/MX9203613A/es unknown
-
1994
- 1994-09-22 JP JP6227610A patent/JPH07223961A/ja active Pending
- 1994-10-27 US US08/330,043 patent/US5534503A/en not_active Expired - Fee Related
-
1995
- 1995-01-18 SG SG8695A patent/SG8695G/en unknown
- 1995-05-11 HK HK70895A patent/HK70895A/xx not_active IP Right Cessation
- 1995-06-02 HU HU95P/P00151P patent/HU211248A9/hu unknown
- 1995-12-01 CY CY182995A patent/CY1829A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6782090A (en) | 2-substituted phenyl-2-oxazoline or thiazoline derivatives, process for producing the same and insectides and acaricides containing the same | |
| ES2066000T3 (es) | Compuestos derivados de pirimidinediona, metodo de produccion de los mismos y agentes antirritmicos que los contienen. | |
| NO171684C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktiv polyetylenglykolkarbaminater | |
| DE69012840D1 (de) | Adenosin-Derivate, die eine Aktivität gegen Bluthochdruck haben. | |
| DE3889345D1 (de) | Schimmelbekämpfungsmittel. | |
| HUP0300497A2 (hu) | Humán foszfatidilinozit-3-kináz-delta inhibitorok és alkalmazásuk | |
| SE8904186D0 (sv) | Adenosine derivatives, their production and use | |
| HUP0100149A2 (hu) | Picorna-vírus-ellenes peptidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| HUP0402385A2 (hu) | 5-Fenil-pirimidinek, ezeket tartalmazó fungicid készítmények, eljárás előállításukra és alkalmazásuk | |
| DE69104593D1 (de) | Herstellung und Verwendung von N-Jodopropargyl-oxycarbonylaminosäure-Estern als antimicrobielle Mittel. | |
| DE69709795D1 (de) | Neuraminsäuredervate, ihre Herstellung und medizinische Verwendung | |
| ATE34394T1 (de) | Therapeutisch aktive di-, tri-, tetra- und penta- aza-indene. | |
| NO971142L (no) | Bis-(2-halogenetyl)aminofenylsubstituerte distamycinderivater som antitumor- og antivirale midler | |
| FI940425A (sv) | Modifierade oligodeoxiribonukleotider, deras framställning och deras terapeutiska användning | |
| ATE116645T1 (de) | Chromenderivate, deren herstellung und verwendung. | |
| TR200003877T2 (tr) | İnsan CD23 üretiminin ve TNF salınmasının ihhibitörleri olan hiydroxamic acid türevleri | |
| DE3560829D1 (de) | Enkephalinase inhibitors | |
| ES2098346T3 (es) | Inhibidores de la dihidrofolato reductasa de pneumocystis carinii. | |
| DE69029069D1 (de) | Verwendung von Xanthinderivaten gegen Magengeschwüre | |
| DE59107152D1 (de) | Azolylmethylspiro-2.5-octanole und diese enthaltende Fungizide | |
| DK0500348T3 (da) | Disubstituerede urinstoffer og thiourinstoffer | |
| FR2448544A1 (fr) | Derives de thiazole et leur application en therapeutique | |
| EP0396078A3 (de) | 1-Hydroxi-azolverbindungen und diese enthaltende Fungizide | |
| DK380482A (da) | 1-aryloxy-3-alkylamino-2-propanoler og fremgangsmaade til deres fremstilling | |
| ECSP993025A (es) | Inhibidores no peptidilicos de la union a las celulas dependientes de vla -4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8904186-7 Format of ref document f/p: F |